首頁 > 市場調查報告書 > 製藥

再生醫學

市場調查報告書

商品編碼

1547697

全球富血小板血漿市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Platelet Rich Plasma Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到2032年，全球富血小板血漿市場的市場規模將從2023年的4.3158億美元達到近11.7297億美元，2024-2032年研究期間的複合年成長率為11.75%。

富含血小板的血漿（PRP）是人體血液的一種成分，含有能夠促進血液凝固的蛋白質，並且可以促進其來源的人的癒合。當 PRP 注入受損組織時，它會刺激身體生長新的健康細胞，從而促進癒合。 PRP 的製備方法是從人體內抽取血液，然後將其經過兩個階段的離心，將 PRP 與紅血球和貧血小板血漿分離。 PRP 療法可治療患有慢性肌腱炎、骨關節炎、肌腱損傷、急性損傷、脫髮、口腔手術和整形手術的患者。這種療法不會立即產生效果。

市場動態

PRP 療法的各種優勢，如疼痛很少或無痛、恢復更快、手術後不會留下疤痕組織，是該市場成長的關鍵驅動力。這種療法的簡單性將進一步推動其替代移植的使用。運動相關傷害發生率的上升和整容手術的普及將推動該市場的成長。 PRP 在老年人群中越來越受歡迎，因為該過程絕對不存在感染或過敏反應的風險。人們越來越認知到富血小板血漿治療牙齒健康的效率將成為市場的助力。 PRP 的一個主要缺點是它對肘部、肌肉和肌腱以外的區域無效。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球富血小板血漿市場的各個細分市場進行了包容性評估。富血小板血漿產業的成長和趨勢為本研究提供了整體方法。

市場區隔

富血小板血漿市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按類型

純PRP
富含白血球的PRP
純PRF

按產地

自體
同種異體
同源

按申請

骨科手術
整容手術
一般外科
神經外科
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲富血小板血漿市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。富血小板血漿市場的主要參與者包括 Zimmer Biomet Holdings Inc.、AdiStem Ltd.、ISTO Biologics、ThermoGenesis Holdings Inc.、Stryker Corporation、Exactech Inc.、EmCyte Corporation、Regen Lab、Arthrex Inc.、Terumo BCT, Inc.。 (Terumo Corporation)、DePuy Synthes Companies (Johnson & Johnson)、APEX Biologix LLC。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：富血小板血漿公司的競爭格局

富血小板血漿市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Zimmer Biomet Holdings Inc.

公司概況
公司收入
產品
最新動態

AdiStem Ltd.

公司概況
公司收入
產品
最新動態

ISTO Biologics

公司概況
公司收入
產品
最新動態

ThermoGenesis Holdings Inc.

公司概況
公司收入
產品
最新動態

Stryker Corporation

公司概況
公司收入
產品
最新動態

Exactech Inc.

公司概況
公司收入
產品
最新動態

EmCyte Corporation

公司概況
公司收入
產品
最新動態

Regen Lab

公司概況
公司收入
產品
最新動態

Arthrex Inc.

公司概況
公司收入
產品
最新動態

Terumo BCT Inc. (Terumo Corporation)

公司概況
公司收入
產品
最新動態

DePuy Synthes Companies (Johnson & Johnson)

公司概況
公司收入
產品
最新動態

APEX Biologix LLC

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11213862

The global demand for Platelet Rich Plasma Market is presumed to reach the market size of nearly USD 1172.97 Million by 2032 from USD 431.58 Million in 2023 with a CAGR of 11.75% under the study period 2024-2032.

Platelet-rich plasma, or PRP, is a component of human blood that contains proteins to enable blood clotting and can promote healing in a person it is derived from. When PRP is injected into the damaged tissues, it stimulates the body to grow new, healthy cells and thus promotes healing. PRP is prepared by deriving blood from the person and then passing it through two stages of centrifugation to separate PRP from red blood cells and platelet-poor plasma. PRP therapy treats patients with chronic tendinitis, osteoarthritis, tendon injuries, acute injuries, hair loss conditions, oral surgery, and plastic surgery. This therapy does not provide immediate results.

MARKET DYNAMICS

PRP therapy's various advantages like little or no pain, faster recovery, and no scar tissue over surgery are the key driving force behind this market's growth. The simplicity of this therapy will further propel its use in place of transplants. Rising incidences of sports-related injuries and increased adoption of cosmetic procedures will boost the growth of this market. PRP is becoming very popular among the geriatric community since there is absolutely no risk of infection or allergic reactions involved in the process. Growing awareness about the efficiency of platelet-rich plasma treatment in dental health will be a market booster. PRP's single major drawback is its ineffectiveness in treating areas other than the elbow, muscles, and tendons.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Platelet Rich Plasma. The growth and trends of Platelet Rich Plasma industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Platelet Rich Plasma market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Pure-PRP
Leukocyte-rich PRP
Pure-PRF

By Origin

Autologous
Allogeneic
Homologous

By Application

Orthopedic Surgery
Cosmetic Surgery
General Surgery
Neurosurgery
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Platelet Rich Plasma market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Platelet Rich Plasma market include Zimmer Biomet Holdings Inc., AdiStem Ltd., ISTO Biologics, ThermoGenesis Holdings Inc., Stryker Corporation, Exactech Inc., EmCyte Corporation, Regen Lab, Arthrex Inc., Terumo BCT, Inc. (Terumo Corporation), DePuy Synthes Companies (Johnson & Johnson), APEX Biologix LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PLATELET RICH PLASMA - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Origin
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Pure-PRP Historic and Forecast Sales By Regions
5.4. Leukocyte-rich PRP Historic and Forecast Sales By Regions
5.5. Pure-PRF Historic and Forecast Sales By Regions

6. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY ORIGIN

6.1. Overview By Origin
6.2. Historical and Forecast Data Analysis By Origin
6.3. Autologous Historic and Forecast Sales By Regions
6.4. Allogeneic Historic and Forecast Sales By Regions
6.5. Homologous Historic and Forecast Sales By Regions

7. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data Analysis By Application
7.3. Orthopedic Surgery Historic and Forecast Sales By Regions
7.4. Cosmetic Surgery Historic and Forecast Sales By Regions
7.5. General Surgery Historic and Forecast Sales By Regions
7.6. Neurosurgery Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PLATELET RICH PLASMA COMPANIES

9.1. Platelet Rich Plasma Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF PLATELET RICH PLASMA INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Zimmer Biomet Holdings Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. AdiStem Ltd.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. ISTO Biologics
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. ThermoGenesis Holdings Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Stryker Corporation
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Exactech Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. EmCyte Corporation
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Regen Lab
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Arthrex Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Terumo BCT Inc. (Terumo Corporation)
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. DePuy Synthes Companies (Johnson & Johnson)
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. APEX Biologix LLC
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments